脑转移瘤手术切除前的新辅助立体定向放射外科治疗
该回顾性研究纳入2011至2015年在德克萨斯大学西南医学中心接受新辅助立体定向放射外科(NaSRS)后行脑转移瘤手术切除的12例患者,中位随访13个月,6个月和12个月局部控制率分别为81.8%和49.1%,总体生存率分别为83.3%和74.1%,作者认为NaSRS安全有效,但需进一步随机研究。
要点
- 12例脑转移瘤患者接受新辅助立体定向放射外科后手术切除,中位随访13个月。
- 6个月和12个月局部控制率分别为81.8%和49.1%,总体生存率分别为83.3%和74.1%。
- 2例患者平均11.3个月时发生柔脑膜疾病,肿瘤体积和直径较大时局部失败有增加趋势(P=0.06)。
核心结论
- NaSRS是治疗需要手术干预的特定脑转移瘤的一种有前景的新方法,在实现局部控制方面安全有效。
- 需要更大患者队列的进一步随机研究来确定长期结局是否改善。
研究设计与样本
- 回顾性综述,纳入2011至2015年在德克萨斯大学西南医学中心接受新辅助立体定向放射外科(NaSRS)后行脑转移瘤手术切除的12例患者。
- 采用Kaplan-Meier和log-rank分析表征复发和总体生存。
主要发现
- 患者平均年龄57.5岁(范围39-69),中位随访13个月(范围1-22.6),中位最大肿瘤直径3.66 cm(范围2.19-4.85)。
- 6个月和12个月局部控制率分别为81.8%和49.1%。
- 6个月和12个月远处疾病控制率分别为72.7%和14.5%。
- 6个月和12个月总体生存率分别为83.3%和74.1%。
- 2例患者平均11.3个月时发生柔脑膜疾病;肿瘤体积和直径较大时局部失败有增加趋势(P=0.06)。
局限性
- 原文报告为回顾性综述。
- 样本量为12例。
- 作者指出需要更大患者队列的进一步随机研究来确定长期结局是否改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Stereotactic radiosurgery (SRS) has redefined the treatment paradigm for cerebral metastases. The benefits of SRS after surgical resection of a metastatic brain tumor have been well-defined. However, it is unclear whether preoperative SRS can improve the outcomes in select patients. The present study examined the safety and efficacy of preoperative neoadjuvant SRS (NaSRS) for the treatment of cerebral metastases. METHODS: We performed a retrospective review of 12 patients treated at The University of Texas Southwestern Medical Center. All patients underwent NaSRS, followed by surgical resection of a cerebral metastasis, from 2011 to 2015. Recurrence and overall survival were characterized using Kaplan-Meier and log-rank analyses. RESULTS: The mean age was 57.5 years (range, 39-69). The median follow-up period was 13 months (range, 1-22.6). The median maximum tumor diameter was 3.66 cm (range, 2.19-4.85). The 6- and 12-month local control rates were 81.8% and 49.1%, respectively. The distant disease control rates were 72.7% and 14.5% at 6 and 12 months, respectively. Overall survival was 83.3% and 74.1% at 6 and 12 months, respectively. Two patients developed leptomeningeal disease at a mean of 11.3 months. A trend toward increased local failure was seen with larger tumor volumes and diameters (P = 0.06). CONCLUSIONS: NaSRS is a promising new approach for the treatment of select cerebral metastases that require surgical intervention. The approach is safe and effective at achieving local control. Further randomized studies with larger patient cohorts are necessary to determine whether the long-term outcomes are improved.
引用
- Patel AR, Nedzi L, Lau S, et al. Neoadjuvant Stereotactic Radiosurgery Before Surgical Resection of Cerebral Metastases. World Neurosurg. 2018. PMID: 30149167. doi:10.1016/j.wneu.2018.08.107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。